COPS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.747200E-01
Normal-vs-Stage2
9.069800E-01
Normal-vs-Stage3
3.987800E-01
Normal-vs-Stage4
3.577600E-01
Stage1-vs-Stage2
9.116600E-01
Stage1-vs-Stage3
1.753960E-01
Stage1-vs-Stage4
4.100200E-01
Stage2-vs-Stage3
3.225400E-01
Stage2-vs-Stage4
5.165400E-01
Stage3-vs-Stage4
7.956100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.078600E-01
Normal-vs-AfricanAmerican
9.141800E-01
Normal-vs-Asian
6.099000E-01
Caucasian-vs-AfricanAmerican
9.699000E-01
Caucasian-vs-Asian
1.866410E-01
AfricanAmerican-vs-Asian
4.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.997800E-01
Normal-vs-Female
8.133400E-01
Male-vs-Female
4.183400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.762800E-01
Normal-vs-Age(41-60Yrs)
5.551200E-01
Normal-vs-Age(61-80Yrs)
9.063800E-01
Normal-vs-Age(81-100Yrs)
7.933400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.807200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.076600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.591000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.265580E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.227610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.334400E-01
Normal-vs-Daily Drinker
8.200600E-01
Normal-vs-Weekly Drinker
6.555400E-01
Normal-vs-Occasional Drinker
6.355000E-01
Normal-vs-Social Drinker
9.306400E-01
Non Drinker-vs-Daily Drinker
9.865600E-01
Non Drinker-vs-Weekly Drinker
7.579400E-01
Non Drinker-vs-Occasional Drinker
8.924200E-02
Non Drinker-vs-Social Drinker
4.272400E-01
Daily Drinker-vs-Weekly Drinker
8.099000E-01
Daily Drinker-vs-Occasional Drinker
1.923030E-01
Daily Drinker-vs-Social Drinker
5.645800E-01
Weekly Drinker-vs-Occasional Drinker
1.307590E-01
Weekly Drinker-vs-Social Drinker
3.784800E-01
Occasional Drinker-vs-Social Drinker
4.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.156370E-01
Normal-vs-Grade 2
2.250100E-02
Normal-vs-Grade 3
3.600200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.898200E-02
Grade 1-vs-Grade 3
3.028400E-02
Grade 1-vs-Grade 4
1.156370E-01
Grade 2-vs-Grade 3
6.383200E-01
Grade 2-vs-Grade 4
2.250100E-02
Grade 3-vs-Grade 4
3.600200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.332600E-01
Normal-vs-NonDiabetic
9.281600E-01
Diabetic-vs-NonDiabetic
2.119800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.032600E-01
Normal-vs-NoPancreatitis
9.339400E-01
Pancreatitis-vs-NoPancreatitis
4.923400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.483200E-01
Normal-vs-N1
8.444000E-01
N0-vs-N1
3.659600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.948200E-01
Normal-vs-TP53-NonMutant
9.301200E-01
TP53-Mutant-vs-TP53-NonMutant
3.536000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
